‘Uncharted Territory’: Gilead Releases Pricing Details For Only Known Coronavirus Treatment
Under the pricing structure announced by Gilead Sciences Monday, a hospital in the U.S. would be charged $3,120 for remdesivir in order to treat a typical patient with insurance.